1 active not recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Ulcerative Colitis Chronic: new trials by email Literature Review of Ulcerative Colitis Chronic trials Research Report on Ulcerative Colitis Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis Eltrekibart, Mirikizumab, Placebo - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 2 | Active not recruiting | Eli Lilly and Company | 143 | 2024-10-10 | 2026-10-07 |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2022-06-01 | 2022-04-22 |
Colitis, Ulcerative (2) · Colitis (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Inflammatory Bowel Diseases (1) · Intestinal Diseases (1)
Gastroenteritis (2) · Colitis (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Inflammatory Bowel Diseases (1) · Intestinal Diseases (1)
Prednisolone (1) · mirikizumab (1)
Assiut University (1) · Eli Lilly and Company (1)
Argentina (1) · Belgium (1) · Canada (1) · Colombia (1) · Croatia (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Ireland (1) · Italy (1) · Japan (1) · Latvia (1)